Jeffrey J Wallin (Jeffrey Wallin)

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Venues

European journal of immunology

Communications medicine

Viruses

Pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Yanhui Cai, Ondrej Podlaha, Steven G Deeks, Cynthia Brinson, Moti N Ramgopal, Edwin DeJesus, Anthony Mills, Peter Shalit, Mohamed Abdel-Mohsen, Liao Zhang, Christiaan R de Vries, Elena Vendrame, Devi SenGupta, Jeffrey J Wallin
HIV rebound in HIV controllers is associated with a specific fecal microbiome profile. European journal of immunology (2024)
Yanhui Cai, Ondrej Podlaha, Steven G Deeks, Cynthia Brinson, Moti N Ramgopal, Edwin DeJesus, Anthony Mills, Peter Shalit, Mohamed Abdel-Mohsen, Liao Zhang, Christiaan R de Vries, Elena Vendrame, Devi SenGupta, Jeffrey J Wallin
HIV rebound in HIV controllers is associated with a specific fecal microbiome profile. European journal of immunology 54 (8) (2024)
David Z Pan, Pamela M Odorizzi, Andre Schoenichen, Mazin Abdelghany, Shuguang Chen, Anu Osinusi, Scott D Patterson, Bryan Downie, Kavita Juneja, Jeffrey J Wallin
Remdesivir improves biomarkers associated with disease severity in COVID-19 patients treated in an outpatient setting. Communications medicine 3 (1) (2023)
David Z Pan, Pamela M Odorizzi, Andre Schoenichen, Mazin Abdelghany, Shuguang Chen, Anu Osinusi, Scott D Patterson, Bryan Downie, Kavita Juneja, Jeffrey J Wallin
Remdesivir improves biomarkers associated with disease severity in COVID-19 patients treated in an outpatient setting. Communications medicine 3 (1) (2023)
Rajbharan Yadav, Siddharth Sukumaran, Tanja S Zabka, Jinze Li, Amy Oldendorp, Gary Morrow, Arthur Reyes, Melissa Cheu, Jessica Li, Jeffrey J Wallin, Siao Tsai, Laura Sun, Peiyin Wang, Diego Ellerman, Christoph Spiess, Andy Polson, Eric G Stefanich, Amrita V Kamath, Meric A Ovacik
Nonclinical Pharmacokinetics and Pharmacodynamics Characterization of Anti-CD79b/CD3 T Cell-Dependent Bispecific Antibody Using a Surrogate Molecule: A Potential Therapeutic Agent for B Cell Malignancies. Pharmaceutics 14 (5) (2022)
Minchao Li, Jinfeng Zeng, Ruiting Li, Ziyu Wen, Yanhui Cai, Jeffrey J Wallin, Yuelong Shu, Xiangjun Du, Caijun Sun
Rational Design of a Pan-Coronavirus Vaccine Based on Conserved CTL Epitopes. Viruses 13 (2) (2021)

Jeffrey J Wallin.css-eqlu8i{font-size:small;padding-left:4px;} (Jeffrey Wallin)

Publication Activity (10 Years)

Top Topics

Top Venues

Jeffrey J Wallin (Jeffrey Wallin)